OBJECTIVES: Genetic susceptibility is known to play a large part in the predisposition to the inflammatory bowel diseases (IBDs) known as Crohn's disease (CD) and ulcerative colitis (UC). The IL2/IL21 locus on 4q27 is known to be a common risk locus for inflammatory disease (shown in coeliac disease, type 1 diabetes, rheumatoid arthritis, systemic lupus erythematosus and psoriasis), while the roles that interleukin 2 (IL2) and IL21 play in the immune response also make them attractive candidates for IBD. The objective of this study was to test for association between the IL2/IL21 locus and the IBDs. METHODS: The four single nucleotide polymorphisms (SNPs) in the IL2/IL21 locus most associated with coeliac disease were genotyped in 1590 subjects with IBD and 929 controls from The Netherlands, and then replicated in a North American cohort (2387 cases and 1266 controls) and an Italian cohort (805 cases and 421 controls), yielding a total of 4782 cases (3194 UC, 1588 CD) and 2616 controls. Allelic association testing and a pooled analysis using a Cochran-Mantel-Haenszel test were performed. RESULTS: All four SNPs were strongly associated with UC in all three cohorts and reached genome-wide significance in the pooled analysis (rs13151961 p = 1.35 x 10(-10), rs13119723 p = 8.60 x 10(-8), rs6840978 p = 3.0 7x 10(-8), rs6822844 p = 2.77 x 10(-9)). A moderate association with CD was also found in the pooled analysis (p value range 0.0016-9.86 x 10(-5)). CONCLUSIONS: A strong association for the IL2/IL21 locus with UC was found, which also confirms it as a general susceptibility locus for inflammatory disease.
OBJECTIVES: Genetic susceptibility is known to play a large part in the predisposition to the inflammatory bowel diseases (IBDs) known as Crohn's disease (CD) and ulcerative colitis (UC). The IL2/IL21 locus on 4q27 is known to be a common risk locus for inflammatory disease (shown in coeliac disease, type 1 diabetes, rheumatoid arthritis, systemic lupus erythematosus and psoriasis), while the roles that interleukin 2 (IL2) and IL21 play in the immune response also make them attractive candidates for IBD. The objective of this study was to test for association between the IL2/IL21 locus and the IBDs. METHODS: The four single nucleotide polymorphisms (SNPs) in the IL2/IL21 locus most associated with coeliac disease were genotyped in 1590 subjects with IBD and 929 controls from The Netherlands, and then replicated in a North American cohort (2387 cases and 1266 controls) and an Italian cohort (805 cases and 421 controls), yielding a total of 4782 cases (3194 UC, 1588 CD) and 2616 controls. Allelic association testing and a pooled analysis using a Cochran-Mantel-Haenszel test were performed. RESULTS: All four SNPs were strongly associated with UC in all three cohorts and reached genome-wide significance in the pooled analysis (rs13151961 p = 1.35 x 10(-10), rs13119723 p = 8.60 x 10(-8), rs6840978 p = 3.0 7x 10(-8), rs6822844 p = 2.77 x 10(-9)). A moderate association with CD was also found in the pooled analysis (p value range 0.0016-9.86 x 10(-5)). CONCLUSIONS: A strong association for the IL2/IL21 locus with UC was found, which also confirms it as a general susceptibility locus for inflammatory disease.
Authors: Adrienne G Randolph; Christoph Lange; Edwin K Silverman; Ross Lazarus; Eric S Silverman; Benjamin Raby; Alison Brown; Al Ozonoff; Brent Richter; Scott T Weiss Journal: Am J Hum Genet Date: 2004-08-20 Impact factor: 11.025
Authors: Giovanni Monteleone; Ivan Monteleone; Daniele Fina; Piero Vavassori; Giovanna Del Vecchio Blanco; Roberta Caruso; Roberto Tersigni; Luciano Alessandroni; Livia Biancone; Gian Carlo Naccari; Thomas T MacDonald; Francesco Pallone Journal: Gastroenterology Date: 2005-03 Impact factor: 22.682
Authors: Alienke J Monsuur; Paul I W de Bakker; Behrooz Z Alizadeh; Alexandra Zhernakova; Marianna R Bevova; Eric Strengman; Lude Franke; Ruben van't Slot; Martine J van Belzen; Ineke C M Lavrijsen; Begoña Diosdado; Mark J Daly; Chris J J Mulder; M Luisa Mearin; Jos W R Meijer; Gerrit A Meijer; Erica van Oort; Martin C Wapenaar; Bobby P C Koeleman; Cisca Wijmenga Journal: Nat Genet Date: 2005-11-13 Impact factor: 38.330
Authors: E Sánchez; S Morales; L Paco; M A López-Nevot; C Hidalgo; J Jiménez-Alonso; B Torres; M A González-Gay; J L Callejas; N Ortego-Centeno; J Sánchez-Roman; M F González-Escribano; J Martín Journal: Rheumatology (Oxford) Date: 2005-06-07 Impact factor: 7.580
Authors: S Lichtiger; D H Present; A Kornbluth; I Gelernt; J Bauer; G Galler; F Michelassi; S Hanauer Journal: N Engl J Med Date: 1994-06-30 Impact factor: 91.245
Authors: David A van Heel; Lude Franke; Karen A Hunt; Rhian Gwilliam; Alexandra Zhernakova; Mike Inouye; Martin C Wapenaar; Martin C N M Barnardo; Graeme Bethel; Geoffrey K T Holmes; Con Feighery; Derek Jewell; Dermot Kelleher; Parveen Kumar; Simon Travis; Julian R F Walters; David S Sanders; Peter Howdle; Jill Swift; Raymond J Playford; William M McLaren; M Luisa Mearin; Chris J Mulder; Ross McManus; Ralph McGinnis; Lon R Cardon; Panos Deloukas; Cisca Wijmenga Journal: Nat Genet Date: 2007-06-10 Impact factor: 38.330
Authors: Amit K Maiti; Xana Kim-Howard; Parvathi Viswanathan; Laura Guillén; Adriana Rojas-Villarraga; Harshal Deshmukh; Haner Direskeneli; Güher Saruhan-Direskeneli; Carlos Cañas; Gabriel J Tobön; Amr H Sawalha; Alejandra C Cherñavsky; Juan-Manuel Anaya; Swapan K Nath Journal: Arthritis Rheum Date: 2010-02
Authors: Elizabeth A Tindall; Hoa N Hoang; Melissa C Southey; Dallas R English; John L Hopper; Graham G Giles; Gianluca Severi; Vanessa M Hayes Journal: BMC Cancer Date: 2010-02-25 Impact factor: 4.430
Authors: Daniela De Nitto; Massimiliano Sarra; Francesco Pallone; Giovanni Monteleone Journal: World J Gastroenterol Date: 2010-08-07 Impact factor: 5.742
Authors: Daniela De Nitto; Ivan Monteleone; Eleonora Franzè; Francesco Pallone; Giovanni Monteleone Journal: World J Gastroenterol Date: 2009-10-07 Impact factor: 5.742
Authors: Jade E Hollis-Moffatt; Michael Chen-Xu; Ruth Topless; Nicola Dalbeth; Peter J Gow; Andrew A Harrison; John Highton; Peter B B Jones; Michael Nissen; Malcolm D Smith; Andre van Rij; Gregory T Jones; Lisa K Stamp; Tony R Merriman Journal: Arthritis Res Ther Date: 2010-06-16 Impact factor: 5.156